Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16749654 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)
Conditions: Hypercholesterolemia;   Atherosclerosis
Interventions: Drug: Ezetimibe + Simvastatin;   Drug: Simvastatin

Indicates status has not been verified in more than two years